Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00099255
Status:
COMPLETED
Last Update Posted:
2014-12-18
First Post:
2004-12-10
Brief Title:
Study of SGN-30 Anti-CD30 mAb in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Organization Data
Organization:
Seagen Inc
Class:
INDUSTRY
Study ID:
SG030-0004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seagen Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None